ZIMMER BIOMET HOLDINGS, INC. (ZBH) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for ZIMMER BIOMET HOLDINGS, INC. (ZBH): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 51/100 — a percentile rank of ZIMMER BIOMET HOLDINGS, INC.’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.
| Market cap | $16.8B |
| P / E | 20.8× |
| P / S | 2.0× |
| EV / EBITDA | 9.6× |
| Gross margin | 69.9% |
| Operating margin | 14.2% |
| Net margin | 9.5% |
| Return on equity | 6.4% |
| ROIC | 5.3% |
| Revenue growth | 8.6% |
| Debt / equity | 0.6× |
| Dividend yield | 1.1% |
Is ZIMMER BIOMET HOLDINGS, INC. overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from ZIMMER BIOMET HOLDINGS, INC.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact